OPKO HEALTH INC
(NYSE: OPK)

OPKO Health, Inc. (OPKO) is a multi-national biopharmaceutical and diagnostics company. OPKO is developing a range of solutions to diagnose, treat and prevent various conditions, including molecular diagnostics tests, laboratory developed tests (LTDs), point-of-care tests and pharmaceuticals and vaccines. The Company operates in two segments: pharmaceutical and diagnostics. The pharmaceutical segment consists of two operating segments: pharmaceutical research and development segment which is focused on the research and development of pharmaceutical products and vaccines, and the pharmaceutical operations it acquired in Chile, Mexico, Israel, and Spain through acquisitions in those countries. Effective May 28, 2014, OPKO Health Inc acquired Inspiro Medical Ltd, a Misgav-based manufacturer and wholesaler of pharmaceuticals.

1.315

+0.055 (+4.37%)
Range 1.250 - 1.330   (6.40%)
Open 1.250
Previous Close 1.260
Bid Price 6.550
Bid Volume -
Ask Price 6.560
Ask Volume -
Volume 2,179,343
Value -
Remark
Delayed prices. Updated at 14 May 2025 03:05.
Data powered by
View All Events

About OPKO HEALTH INC

OPKO Health, Inc. (OPKO) is a multi-national biopharmaceutical and diagnostics company. OPKO is developing a range of solutions to diagnose, treat and prevent various conditions, including molecular diagnostics tests, laboratory developed tests (LTDs), point-of-care tests and pharmaceuticals and v...
more

Share your investing ideas
Please login to view stock data and analysis